Han M - Search Results

1

Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy.

Pierorazio PM, Ross AE, Lin BM, Epstein JI, Han M, Walsh PC, Partin AW, Pavlovich CP, Schaeffer EM. Pierorazio PM, et al. Among authors: han m. BJU Int. 2012 Oct;110(8):1122-8. doi: 10.1111/j.1464-410X.2012.10986.x. Epub 2012 Feb 28. BJU Int. 2012. PMID: 22373045 Free PMC article.

2

Ability of the 1992 and 1997 American Joint Committee on Cancer staging systems for prostate cancer to predict progression-free survival after radical prostatectomy for stage T2 disease.

Han M, Walsh PC, Partin AW, Rodriguez R. Han M, et al. J Urol. 2000 Jul;164(1):89-92. J Urol. 2000. PMID: 10840430 Free article.

3

A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomy.

Han M, Snow PB, Epstein JI, Chan TY, Jones KA, Walsh PC, Partin AW. Han M, et al. Urology. 2000 Dec 20;56(6):994-9. doi: 10.1016/s0090-4295(00)00815-3. Urology. 2000. PMID: 11113746 Free article.

4

Isolated local recurrence is rare after radical prostatectomy in men with Gleason 7 prostate cancer and positive surgical margins: therapeutic implications.

Han M, Pound CR, Potter SR, Partin AW, Epstein JI, Walsh PC. Han M, et al. J Urol. 2001 Mar;165(3):864-6. J Urol. 2001. PMID: 11176487

5

Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer.

Batuello JT, Gamito EJ, Crawford ED, Han M, Partin AW, McLeod DG, ODonnell C. Batuello JT, et al. Among authors: han m. Urology. 2001 Mar;57(3):481-5. doi: 10.1016/s0090-4295(00)01039-6. Urology. 2001. PMID: 11248624

6

Serum acid phosphatase level and biochemical recurrence following radical prostatectomy for men with clinically localized prostate cancer.

Han M, Piantadosi S, Zahurak ML, Sokoll LJ, Chan DW, Epstein JI, Walsh PC, Partin AW. Han M, et al. Urology. 2001 Apr;57(4):707-11. doi: 10.1016/s0090-4295(00)01073-6. Urology. 2001. PMID: 11306387

7

Evaluation of artificial neural networks for the prediction of pathologic stage in prostate carcinoma.

Han M, Snow PB, Brandt JM, Partin AW. Han M, et al. Cancer. 2001 Apr 15;91(8 Suppl):1661-6. doi: 10.1002/1097-0142(20010415)91:8+<1661::aid-cncr1180>3.3.co;2-x. Cancer. 2001. PMID: 11309765

8

Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy.

Roberts WW, Bergstralh EJ, Blute ML, Slezak JM, Carducci M, Han M, Epstein JI, Eisenberger MA, Walsh PC, Partin AW. Roberts WW, et al. Among authors: han m. Urology. 2001 Jun;57(6):1033-7. doi: 10.1016/s0090-4295(01)00978-5. Urology. 2001. PMID: 11377299

9

Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer.

Han M, Partin AW, Piantadosi S, Epstein JI, Walsh PC. Han M, et al. J Urol. 2001 Aug;166(2):416-9. J Urol. 2001. PMID: 11458039

10

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience.

Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Han M, et al. Urol Clin North Am. 2001 Aug;28(3):555-65. doi: 10.1016/s0094-0143(05)70163-4. Urol Clin North Am. 2001. PMID: 11590814 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,312 results

Search Page

Filters